Results 151 to 160 of about 1,405,405 (194)

Risk factors for macrophage activation syndrome in systemic juvenile idiopathic arthritis: a systematic review and meta-analysis. [PDF]

Front Pediatr
Li S, Wu X, Jing S, Yang X, Zhang Y, Dong L.   +5 more
europepmc   +1 more source

Baseline Clinical Features and Biomarker Profiles of the Childhood Arthritis and Rheumatology Research Alliance Systemic Juvenile Idiopathic Arthritis-Associated Lung Disease Cohort. [PDF]

Arthritis Care Res (Hoboken)
Eloseily E, Riordan ME, Mahmoud I, Clark A, Chang ML, Russell A, Natter M, Thornton S, Canna S, Co DO, DeGuzman M, Kimura Y, Schulert GS, CARRA Registry Investigators, CARRA FROST Investigators, CARRA Registry SJIA‐LD Cohort Investigators.   +15 more
europepmc   +1 more source

Exploration of common genomic signatures of systemic juvenile idiopathic arthritis and Kawasaki disease. [PDF]

Clin Rheumatol
Zhong S, Li Y, Wu L, Di Y.
europepmc   +1 more source

Toward Personalized Withdrawal of TNF-α Inhibitors in Non-Systemic Juvenile Idiopathic Arthritis: Predictors of Biologic-Free Remission and Flare. [PDF]

Pharmaceuticals (Basel)
Alexeeva EI, Tsulukiya IT, Dvoryakovskaya TM, Kriulin IA, Kudlay DA, Fetisova AN, Botova MS, Kriulina TY, Krekhova EA, Kondratyeva NM, Shingarova MS, Kokina MY, Shilova AN, Kostik MM.   +13 more
europepmc   +1 more source

Identification of core genes in systemic juvenile idiopathic arthritis based on 113 machine learning algorithms. [PDF]

Medicine (Baltimore)
Chen Q, Zeng J, Tang H, Sun Y, Wu H, Huang X, Man YN, Li B, He ML, He ML.   +9 more
europepmc   +1 more source

Emapalumab as a Life-Saving Therapy for Macrophage Activation Syndrome in Refractory Systemic Juvenile Idiopathic Arthritis with Trisomy 21. [PDF]

Turk Arch Pediatr
Akay N, Aslan E, Gul U, Kilic Konte E, Yildiz M, Sahin S.   +5 more
europepmc   +1 more source

Hypocomplementemia dynamics during tocilizumab therapy in systemic juvenile idiopathic arthritis: a retrospective longitudinal study. [PDF]

Front Immunol
Ling J, Zhou Q, Xie F, Liu X.
europepmc   +1 more source

A case with systemic juvenile idiopathic arthritis treated with tofacitinib and rapamycin. [PDF]

Rheumatology (Oxford)
Cam V, Sag E, Bilginer Y, Ozen S.
europepmc   +1 more source

Associations of Lymphocyte Subpopulations, Related Cytokines, Clinical Phenotypes, and Outcomes in Systemic Juvenile Idiopathic Arthritis. [PDF]

ACR Open Rheumatol
Lerkvaleekul B, Sitthisarunkul N, Apiwattanakul N, Klinmalai C, Pongsakul N, Vilaiyuk S.   +5 more
europepmc   +1 more source

Innate Lymphoid Cell Phenotypic and Functional Alterations in Patients With Systemic Juvenile Idiopathic Arthritis. [PDF]

Arthritis Rheumatol
Quatrini L, Ciancaglini C, Caiello I, Santopolo S, Pardeo M, Matteo V, Loricchio E, Amodio D, Morrocchi E, Olivieri G, Palma P, Insalaco A, Natale MF, De Matteis A, Tumino N, Bracaglia C, Vacca P, Moretta L, De Benedetti F, Prencipe G.   +19 more
europepmc   +1 more source